Muestra métricas de impacto externas asociadas a la publicación. Para mayor detalle:
| Indexado |
|
||||
| DOI | 10.1002/MRM.30139 | ||||
| Año | 2024 | ||||
| Tipo | artículo de investigación |
Citas Totales
Autores Afiliación Chile
Instituciones Chile
% Participación
Internacional
Autores
Afiliación Extranjera
Instituciones
Extranjeras
Purpose: To develop and validate a highly efficient motion compensated free-breathing isotropic resolution 3D whole-heart joint T-1/T-2 mapping sequence with anatomical water/fat imaging at 0.55 T. Methods: The proposed sequence takes advantage of shorter T-1 at 0.55 T to acquire three interleaved water/fat volumes with inversion-recovery preparation, no preparation, and T-2 preparation, respectively. Image navigators were used to facilitate nonrigid motion-compensated image reconstruction. T-1 and T-2 maps were jointly calculated by a dictionary matching method. Validations were performed with simulation, phantom, and in vivo experiments on 10 healthy volunteers and 1 patient. The performance of the proposed sequence was compared with conventional 2D mapping sequences including modified Look-Locker inversion recovery and T-2-prepared balanced steady-SSFP sequence. Results: The proposed sequence has a good T-1 and T-2 encoding sensitivity in simulation, and excellent agreement with spin-echo reference T-1 and T-2 values was observed in a standardized T-1/T-2 phantom (R-2 = 0.99). In vivo experiments provided good-quality co-registered 3D whole-heart T-1 and T-2 maps with 2-mm isotropic resolution in a short scan time of about 7 min. For healthy volunteers, left-ventricle T-1 mean and SD measured by the proposed sequence were both comparable with those of modified Look-Locker inversion recovery (640 +/- 35 vs. 630 +/- 25 ms [p = 0.44] and 49.9 +/- 9.3 vs. 54.4 +/- 20.5 ms [p = 0.42]), whereas left-ventricle T-2 mean and SD measured by the proposed sequence were both slightly lower than those of T-2-prepared balanced SSFP (53.8 +/- 5.5 vs. 58.6 +/- 3.3 ms [p < 0.01] and 5.2 +/- 0.9 vs. 6.1 +/- 0.8 ms [p = 0.03]). Myocardial T-1 and T-2 in the patient measured by the proposed sequence were in good agreement with conventional 2D sequences and late gadolinium enhancement. Conclusion: The proposed sequence simultaneously acquires 3D whole-heart T-1 and T-2 mapping with anatomical water/fat imaging at 0.55 T in a fast and efficient 7-min scan. Further investigation in patients with cardiovascular disease is now warranted.
| Ord. | Autor | Género | Institución - País |
|---|---|---|---|
| 1 | Si, Dongyue | - |
Kings Coll London - Reino Unido
King's College London - Reino Unido |
| 2 | Crabb, Michael G. | - |
Kings Coll London - Reino Unido
King's College London - Reino Unido |
| 3 | Kunze, Karl P. | Hombre |
Kings Coll London - Reino Unido
Siemens Healthcare Ltd - Reino Unido King's College London - Reino Unido Siemens Healthcare Limited - Reino Unido |
| 4 | Littlewood, Simon J. | - |
Kings Coll London - Reino Unido
King's College London - Reino Unido |
| 5 | PRIETO-VASQUEZ, CLAUDIA DEL CARMEN | Mujer |
Kings Coll London - Reino Unido
Pontificia Universidad Católica de Chile - Chile Millennium Inst Intelligent Healthcare Engn - Chile Instituto Milenio en Ingeniería e Inteligencia Artificial para la Salud - Chile King's College London - Reino Unido |
| 6 | Botnar, Reneprime M. | Hombre |
Kings Coll London - Reino Unido
Pontificia Universidad Católica de Chile - Chile Millennium Inst Intelligent Healthcare Engn - Chile TECH UNIV MUNICH - Alemania Instituto Milenio en Ingeniería e Inteligencia Artificial para la Salud - Chile British Heart Foundation - Reino Unido Technische Universität München - Alemania King's College London - Reino Unido |
| Fuente |
|---|
| British Heart Foundation |
| Department of Health |
| Engineering and Physical Sciences Research Council |
| Wellcome EPSRC Centre for Medical Engineering |
| Technische Universität München |
| National Institute for Health and Care Research |
| Institute for Advanced Studies, University of Bristol |
| National Institute for Health and Research Cardiovascular MedTech Co-operative |
| ANID IMPACT |
| ANID Millennium Institute for Intelligent Healthcare Engineering |
| BHF Center for Award Excellence |
| National Institute for Health and Research Cardiovascular MedTech Co‐operative |
| Basal Center of Interventional Medicine for Precision and Advanced Cellular Therapy |
| Agradecimiento |
|---|
| Wellcome EPSRC Centre for Medical Engineering, Grant/Award Number: NS/A000049/1; the Department of Health through the National Institute for Health Research (NIHR) comprehensive Biomedical Research Centre award; ANID Millenium Institute for Intelligent Healthcare Engineering, Grant/Award Number: ICN2021_004; EPSRC, Grant/Award Number: EP/V044087/1; ANID IMPACT, Basal Center of Interventional Medicine for Precision and Advanced Cellular Therapy, Grant/Award Number: FB210024; British Heart Foundation, Grant/Award Number: RG/20/1/34802; the Technical University of Munich - Institute for Advanced Study; National Institute for Health and Research Cardiovascular MedTech Co-operativeThe authors acknowledge financial support from British Heart Foundation programme grant (RG/20/1/34802) and King's BHF Center for Award Excellence (RE/18/2/34213); EPSRC (EP/V044087/1); Wellcome EPSRC Center for Medical Engineering (NS/A000049/1); ANID Millennium Institute for Intelligent Healthcare Engineering (ICN2021_004); ANID IMPACT, Basal Center of Interventional Medicine for Precision and Advanced Cellular Therapy (FB210024); the Department of Health through the National Institute for Health Research (NIHR) comprehensive Biomedical Research Center award; National Institute for Health and Research Cardiovascular MedTech Co-operative; and the Technical University of Munich-Institute for Advanced Study. The views expressed are those of the authors and not necessarily those of the BHF, NHS, the NIHR, or the Department of Health.r No Statement Availabler No Statement Availabler No Statement Availabler No Statement Availabler No Statement Availabler No Statement Availabler No Statement Available |
| The authors acknowledge financial support from British Heart Foundation programme grant (RG/20/1/34802) and King's BHF Center for Award Excellence (RE/18/2/34213); EPSRC (EP/V044087/1); Wellcome EPSRC Center for Medical Engineering (NS/A000049/1); ANID Millennium Institute for Intelligent Healthcare Engineering (ICN2021_004); ANID IMPACT, Basal Center of Interventional Medicine for Precision and Advanced Cellular Therapy (FB210024); the Department of Health through the National Institute for Health Research (NIHR) comprehensive Biomedical Research Center award; National Institute for Health and Research Cardiovascular MedTech Co\u2010operative; and the Technical University of Munich\u2013Institute for Advanced Study. The views expressed are those of the authors and not necessarily those of the BHF, NHS, the NIHR, or the Department of Health. |